Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy
Marques IP, Madeira MH, Messias AL, Santos T, Martinho AC-V, Figueira J, Cunha-Vaz J.
Clin. Med. 2020, May 12;9(5), 1433; https://doi.org/10.3390/jcm9051433
2020
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290313/pdf/jcm-09-01433.pdf
Different retinopathy phenotypes in type 2 diabetes predict retinopathy progression
Marques IP, Madeira MH, Messias AL, Santos T, Martinho AC-V, Figueira J, Cunha-Vaz J.
Acta Diabetol. 2021 Feb;58(2):197-205. doi: 10.1007/s00592-020-01602-9.
2021
https://link.springer.com/article/10.1007/s00592-020-01602-9
Ocular and systemic risk markers for development of Macular Edema and Proliferative Retinopathy in type 2 diabetes. A five-year longitudinal study
Martinho AC-V, Marques IP, Messias AL, Santos T, Madeira MH, Sousa DC, Cunha-Vaz J.
Diabetes Care. 2021 Jan;44(1):e12-e14. doi: 10.2337/dc20-1125
2021
Development of a Genotype Assay for Age-Related Macular Degeneration: The EYE-RISK Consortium
de Breuk A, Acar IE, Kersten E, Schijvenaars MMVAP, Colijn JM, Haer-Wigman L, Bakker B, de Jong S, Meester-Smoor MA, Timo Verzijden, Missotten TOAR, Monés J, Biarnés M, Pauleikhoff D, Hense HW, Silva R, Nunes S, Melo JB, Fauser S, Hoyng CB, Ueffing M, Coenen MJH, Klaver CCW, den Hollander AI, EYE-RISK Consortium.
Ophthalmology. 2020 Jul 24;S0161-6420(20)30725-9. doi: 10.1016/j.ophtha.2020.07.037.
Use of composite endpoints in early and intermediate age-related macular degeneration clinical trials – state-of-the-art and future directions
Terheyden J.H. Schmitz-Valckenberg S. Crabb D. Dunbar H. Luhmann U. Behning C. Schmid M. Pires I. Cunha-Vaz J. Tufail A. Weissgerber G. Leal S. Holz F.G. Finger R.P.
Ophthalmologica. 2020 Dec 7. doi: 10.1159/000513591.
Phenotypic And Genetic Variations Between Asian And Caucasian Polypoidal Choroidal Vasculopathy Eyes.
Jordan-Yu, JMN, Teo K, Fan Q, Gan JC, Leopoldo AK, Nunes S, Farinha C. Barreto P, Melo JB, Carreira I, Murta JN, Silva R, Cheung CMG
Br. J. Ophthalmol. 317537, (2020). doi: 10.1136/bjophthalmol-2020-317537
https://bjo.bmj.com/content/early/2020/10/13/bjophthalmol-2020-317537.long#
Microglia Dysfunction Caused by the Loss of Rhoa Disrupts Neuronal Physiology and Leads to Neurodegeneration.
Renato Socodato, Camila C.Portugal, Teresa Canedo, Artur Rodrigues, Tiago O.Almeida, Joana F.Henriques, Sandra H.Vaz, João Magalhães, Cátia M.Silva, Filipa I.Baptista, Renata L.Alves Vanessa Coelho-Santos, Ana Paula Silva, Roberto Paes-de-Carvalho, Ana Magalhães, Cord Brakebusch, Ana M.Sebastião, Teresa Summavielle, A. Francisco Ambrosio, João B.Relvas
Cell reports, Volume 31, Issue 12, 23 June 2020, 107796
2020
Use of Artificial Intelligence to Assess Human Emotion.
Thiago Gonçalves dos Santos Martins, Rufino Silva, Luís Guilherme Arneiro Mendes, Paulo Schor.
The Open Psychology Journal.Volume 13, 2020
2020
Transient gain of function of cannabinoid CB1 receptors in the control of frontocortical glucose consumption in a rat model of Type-1 diabetes.
Joana Reis Pedro, Liane I.F. Moura, Ângela Valério-Fernandesa, Filipa I. Baptista, Joana M. Gaspar, Bárbara S. Pinheiro, Cristina Lemos, Fernanda Neutzling D Kaufmanna, Carla Morgado, Carla S. da Silva-Santos, Isaura Tavares, Samira G. Ferreira,Eugénia Carvalhoa, António F. Ambrósio, Rodrigo A. Cunha, João M.N. Duarte, Attila Köfalvia
Brain Research Bulletin Volume 161, August 2020, Pages 106-115 https://doi.org/10.1016/j.brainresbull.2020.05.004
2020
Neuroprotective Strategies for Retinal Ganglion Cell Degeneration: Current Status and Challenges Ahead.
Raquel Boia, Noelia Ruzafa Inês Dinis Aires, Xandra Pereiro ,António Francisco Ambrósio, Elena Vecino and Ana Raquel Santiago
Int. J. Mol. Sci. 2020, 21, 2262; doi:10.3390/ijms21072262
2020
